Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam17 Regulatory News (TM17)

  • There is currently no data for TM17

Director Dealing

7 Nov 2024 15:33

RNS Number : 4196L
Team17 Group PLC
07 November 2024
 

Not for publication, distribution or release, directly or indirectly, in whole or in part, in or into the United States, Australia, Canada, Japan or Republic of South Africa or any other jurisdiction in which such release, publication or distribution would be unlawful.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended). 

 

7 November 2024

 

 

Team17 Group plc

 

("Team17", the "Group" or the "Company")

 

Director Dealing

 

Team17 announces that it has been notified by Debbie Bestwick MBE, Non-Executive Director of the Company (the "Selling Shareholder"), that she has agreed to sell, subject to completion, 3,026,694 ordinary shares of £0.01 each ("Ordinary Shares") in the Company (the "Sale Shares") at a price of £2.10 per Sale Share (the "Sale").

 

Following the Sale, Debbie Bestwick will have a beneficial interest of 27,240,250 Ordinary Shares, representing approximately 18.7 per cent. of the existing issued share capital of the Company.

 

Debbie has agreed not to sell or otherwise dispose of any of her holding of Ordinary Shares for 5 months following completion of the Sale, except with the prior written consent of Peel Hunt LLP ("Peel Hunt").

 

The proceeds of the Sale are payable in cash and will be settled on a T+2 basis (unless otherwise agreed), and settlement of the Sale is expected to occur on or about 11 November 2024.

 

The Company will not receive any proceeds from the Sale.

 

 

Peel Hunt (Nominated Adviser and Broker)

Neil Patel / Benjamin Cryer / Kate Bannatyne

Sohail Akbar

 

 

 

+44 (0)20 7418 8900

 

 

 

About Team17

 

Team17 Group plc is a leading global developer and publisher of video games entertainment to a broad audience. The Group includes a games entertainment label and creative partner for Indie developers, a developer and publisher of educational apps appealing to children under the age of eight and a working simulation games developer and publisher.

 

Visit www.team17.com for more info.

 

Important notice

 

Peel Hunt is authorised and regulated by the Financial Conduct Authority. Peel Hunt is acting for the Selling Shareholder only in connection with the Sale and no one else and will not be responsible to anyone other than the Selling Shareholder for providing the protections offered to clients nor for providing advice in relation to the Sale Shares or the Sale, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

 

 

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Debbie Bestwick MBE

 

2

Reason for the notification

a)

Position/status

Non-Executive Director

 

b) 

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Team17 Group plc

 

b)

LEI

2138006EUUCCL4ZI5E51

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument 

Identification code

Ordinary shares of £0.01 each in the capital of Team17 group plc

 

ISIN GB00BYVX2X20

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£2.10

 

 

3,026,694

 

 

d)

Aggregated information

- Aggregated volume

- Price

N/A - Single Transaction

e)

Date of the transaction

7 November 2024

 

f)

Place of the transaction

London Stock Exchange, XLON

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQKOBNPBDDKDK
Date   Source Headline
19th Sep 20237:00 amRNSHalf Year Results
12th Sep 20239:00 amRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSBoard Update
17th Aug 20234:46 pmRNSHolding(s) in Company
14th Aug 20239:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSNotice of Results & Trading Update
19th Jul 20237:00 amRNSDirectorate Changes
18th Jul 20232:15 pmRNSDirector/PDMR Shareholding
14th Jul 20237:00 amRNSAppointment of Joint Corporate Broker
12th Jul 20233:36 pmRNSDirector/PDMR Shareholding
22nd Jun 20232:01 pmRNSResult of AGM
16th Jun 20234:27 pmRNSHolding(s) in Company
14th Jun 20238:55 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAppointment of Group Chief Executive Officer
26th May 20237:01 amRNSBoard Update
26th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
25th May 20234:42 pmRNSHolding(s) in Company
15th May 202312:50 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTeam17's astragon Acquires Independent Arts
13th Apr 20233:40 pmRNSIssue of Shares
12th Apr 20238:20 amRNSDirector/PDMR Shareholding
31st Mar 202311:15 amRNSDirector/PDMR Shareholding
28th Mar 20237:01 amRNSDirector Update
28th Mar 20237:00 amRNSUnaudited Final Results 2022
13th Mar 20234:49 pmRNSDirector/PDMR Shareholding
13th Mar 20239:05 amRNSNo Material Exposure to Silicon Valley Bank
2nd Mar 20237:00 amRNSNotice of Results & Analyst/Investor Presentations
13th Feb 20231:41 pmRNSDirector/PDMR Shareholding
31st Jan 20232:40 pmRNSHoldings in Company
19th Jan 20235:20 pmRNSHolding(s) in Company
18th Jan 20237:00 amRNSTrading Update
12th Jan 20239:04 amRNSDirector/PDMR Shareholding
10th Jan 20236:19 pmRNSHolding(s) in Company
9th Jan 20232:48 pmRNSTrading Update
13th Dec 20223:51 pmRNSDirector/PDMR Shareholding
17th Nov 20228:46 amRNSHolding(s) in Company
11th Nov 20225:13 pmRNSDirector/PDMR Shareholding
20th Oct 202212:11 pmRNSHolding(s) in Company
18th Oct 20221:42 pmRNSDirector/PDMR Shareholding
13th Sep 20224:32 pmRNSDirector/PDMR Shareholding
13th Sep 20227:00 amRNSHalf Year Results
5th Sep 20227:00 amRNSNotice of Results & Analyst/Investor presentations
12th Aug 20221:29 pmRNSDirector/PDMR Shareholding
18th Jul 20225:08 pmRNSHolding(s) in Company
15th Jul 20223:25 pmRNSHolding(s) in Company
14th Jul 20227:00 amRNSTrading Update
12th Jul 20223:56 pmRNSDirector/PDMR Shareholding
30th Jun 20223:58 pmRNSGrant of Options to Directors / PDMRs
29th Jun 20224:39 pmRNSResult of AGM
15th Jun 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.